UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DreamMakers: Innovating for the Greater Good

Hunt, Michele

1, 2017

Volltextzugriff (PDF)

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Gut, 2021-04, Vol.70 (4), p.725-732

2021

Volltextzugriff (PDF)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Gastroenterology (New York, N.Y. 1943), 2022-01, Vol.162 (1), p.316-319.e5

2022

Volltextzugriff (PDF)

ProQuest Black Studies

Charleston advisor, 2022-10, Vol.24 (2), p.39-42

Hunt, Michele N.

2022

Volltextzugriff (PDF)

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

The American journal of gastroenterology, 2006-07, Vol.101 (7), p.1546-1550

2006

Volltextzugriff (PDF)

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.481-491.e3

2020

Volltextzugriff (PDF)

INNOVATING FOR THE GREATER GOOD

Leader to leader, 2017-10, Vol.2017 (86), p.6-11

Hunt, Michele

2017

Volltextzugriff (PDF)

INNOVATING FOR THE GREATER GOOD: THE NEW DEFINITION OF SUCCESS

Leader to leader, 2017-09, Vol.2017 (86), p.6-11

Hunt, Michele

2017

Volltextzugriff (PDF)

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1779-1785

2020

Volltextzugriff (PDF)

The BURDEN IBS-C Study (Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients With Irritable Bowel Syndrome With Constipation): 476

The American journal of gastroenterology, 2017-10, Vol.112, p.S251

2017

Volltextzugriff (PDF)

The Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation (BURDEN-CIC) Study: Results of an Online Questionnaire

Advances in therapy, 2017-12, Vol.34 (12), p.2661-2673

2017

Volltextzugriff (PDF)

Provider Knowledge and Recommendations Regarding Ileoanal Pouch Surgery and Fertility in Women with Ulcerative Colitis

Inflammatory bowel diseases, 2022-09, Vol.28 (9), p.1454-1457

2022

Volltextzugriff (PDF)

Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-525-S-525

2021

Volltextzugriff (PDF)

Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire

Advances in therapy, 2018-07, Vol.35 (7), p.967-980

2018

Volltextzugriff (PDF)

The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis

Inflammatory bowel diseases, 2022-11, Vol.28 (11), p.1687-1695

2022

Volltextzugriff (PDF)

Su1533 - Results from the Burden-CIC Study (Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation)

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S512-S512

2017

Volltextzugriff (PDF)

Results from the Burden-CIC Study (Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation)

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S512-S512

2017

Volltextzugriff (PDF)

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

Clinical gastroenterology and hepatology, 2021-10, Vol.19 (10), p.2210-2213.e3

2021

Volltextzugriff (PDF)

Early VTE prophylaxis in severe traumatic brain injury: A propensity score weighted EAST multicenter study

The journal of trauma and acute care surgery, 2023-07, Vol.95 (1), p.94-104

2023

Volltextzugriff (PDF)

Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter study

Injury, 2024-09, Vol.55 (9), p.111523, Article 111523

2024

Volltextzugriff (PDF)

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

Journal of Crohn's and colitis, 2021-05, Vol.15 (5), p.860-863

2021

Volltextzugriff (PDF)

Peter Drucker: A generous spirit

Leader to leader, 2010, Vol.2010 (S1), p.27-32

Hunt, Michele

2010

Volltextzugriff (PDF)

Efficacy and Safety of Rifaximin as Maintenance Therapy for Mild-Moderate Crohnʼs Disease Refractory to Multiple Medical Therapies: 952

The American journal of gastroenterology, 2007-09, Vol.102, p.S468

2007

Volltextzugriff (PDF)

A Prospective, Controlled Longitudinal Study of the Effects of Oral Steroids at 3, 6 and 12 Months on Bone Mineral Density (BMD) in Patients with IBD: 1146

The American journal of gastroenterology, 2008-09, Vol.103, p.S448

2008

Volltextzugriff (PDF)

Efficacy and Safety of Open Label Rifaximin in the Treatment of Mild-Moderate Crohnʼs Disease (CD) Refractory to Multiple Medical Therapies: 1150

The American journal of gastroenterology, 2006-09, Vol.101, p.S449

2006

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(155)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(199)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

DreamMakers: Innovating for the Greater Good

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

ProQuest Black Studies

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

INNOVATING FOR THE GREATER GOOD

INNOVATING FOR THE GREATER GOOD: THE NEW DEFINITION OF SUCCESS

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

The BURDEN IBS-C Study (Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients With Irritable Bowel Syndrome With Constipation): 476

The Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation (BURDEN-CIC) Study: Results of an Online Questionnaire

Provider Knowledge and Recommendations Regarding Ileoanal Pouch Surgery and Fertility in Women with Ulcerative Colitis

Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS

Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire

The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis

Su1533 - Results from the Burden-CIC Study (Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation)

Results from the Burden-CIC Study (Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation)

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States

Early VTE prophylaxis in severe traumatic brain injury: A propensity score weighted EAST multicenter study

Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter study

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

Peter Drucker: A generous spirit

Efficacy and Safety of Rifaximin as Maintenance Therapy for Mild-Moderate Crohnʼs Disease Refractory to Multiple Medical Therapies: 952

A Prospective, Controlled Longitudinal Study of the Effects of Oral Steroids at 3, 6 and 12 Months on Bone Mineral Density (BMD) in Patients with IBD: 1146

Efficacy and Safety of Open Label Rifaximin in the Treatment of Mild-Moderate Crohnʼs Disease (CD) Refractory to Multiple Medical Therapies: 1150

Suchergebnisse filtern